June is a time when good baseball teams start to pull away from the pack, and a football team is beginning to take shape for the season ahead. It’s a time to honor Father’s Day, celebrate the Summer ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

Wider resection of localized high-risk prostate cancer at surgery may come at the cost of sexual function and urinary incontinence. A phase 2 trial tested the merits of neoadjuvant therapy.

BUFFALO, N.Y. and WASHINGTON, D.C. — Experts from Roswell Park Comprehensive Cancer Center were invited to share their findings at the annual meeting of the American Urological Association (AUA) in ...

Nerve-sparing in high-risk patients undergoing robot-assisted laparoscopic prostatectomy (RALP) for prostate cancer. We are investigating the oncological effect of nerve sparing for men with high-risk ...

Real-world, prospective data corroborate trial results showing functional declines after prostate cancer surgery, despite progress in nerve-sparing techniques. Active surveillance best preserves ...

Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated with faster recovery of erectile function, a 10-year, single-center study ...

PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell Limited (ASX: OCC) is pleased to announce adoption of Remplir™ by Australian urologists is accelerating with the product increasingly being ...

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell ...

Orthocell (ASX: OCC) has confirmed accelerating adoption of lead product Remplir by Australian urologists, with the product so far used in approximately 100 prostate cancer surgeries nationwide to ...